--- title: "Elevance Health, Inc. (ELV.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/ELV.US.md" symbol: "ELV.US" name: "Elevance Health, Inc." industry: "Managed Health Care" --- # Elevance Health, Inc. (ELV.US) | Item | Detail | |------|--------| | Industry | Managed Health Care | | Location | US Market | | Website | [www.elevancehealth.com](https://www.elevancehealth.com) | ## Company Profile Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer grou... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:13.000Z **Overall: B (0.33)** **Industry**: Managed Health Care | Metric | Value | |--------|-------| | Industry Ranking | 2 / 10 | | Industry Median | B | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Large - The company has stable operations, allowing for dependable long-term returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 12.62% | | | Net Profit YoY | -5.32% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 1.75 | | | Dividend Ratio | 1.96% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 76.84B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 199.13B | | **Multi Score**: B #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 13.29% | B | | Profit Margin | 2.84% | C | | Gross Margin | 25.56% | C | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 12.62% | B | | Net Profit YoY | -5.32% | C | | Total Assets YoY | 3.94% | C | | Net Assets YoY | 6.28% | B | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 3516.88% | A | | OCF YoY | 12.62% | B | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.67 | A | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 63.76% | D | ```chart-data:radar { "title": "Longbridge Financial Score - Elevance Health, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "13.29%", "rating": "B" }, { "name": "Profit Margin", "value": "2.84%", "rating": "C" }, { "name": "Gross Margin", "value": "25.56%", "rating": "C" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "12.62%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-5.32%", "rating": "C" }, { "name": "Total Assets YoY", "value": "3.94%", "rating": "C" }, { "name": "Net Assets YoY", "value": "6.28%", "rating": "B" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "3516.88%", "rating": "A" }, { "name": "OCF YoY", "value": "12.62%", "rating": "B" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.67", "rating": "A" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "63.76%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Unitedhealth (US.UNH) | B | C | A | D | B | B | | 02 | Elevance Health (US.ELV) | B | B | A | D | B | B | | 03 | Humana (US.HUM) | C | B | A | D | A | B | | 04 | Molina Healthcare (US.MOH) | C | C | A | D | A | B | | 05 | HealthEquity (US.HQY) | B | B | C | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 13.57 | 1/9 | 15.28 | 14.08 | 13.04 | | PB | 1.75 | 3/9 | 2.18 | 1.81 | 1.63 | | PS (TTM) | 0.39 | 4/9 | 0.51 | 0.41 | 0.37 | | Dividend Yield | 1.97% | 2/9 | 2.13% | 1.93% | 1.64% | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-18T05:00:00.000Z Total Analysts: **23** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 11 | 48% | | Overweight | 3 | 13% | | Hold | 8 | 35% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 342.43 | | Highest Target | 474.00 | | Lowest Target | 332.00 | ## References - [Company Overview](https://longbridge.com/en/quote/ELV.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/ELV.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/ELV.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.